rethinkTHC Search
Menu
Study breakdown

A full-spectrum hemp extract was more effective than CBD alone at preventing meth relapse in rats

Animal StudyPreliminary evidence
The takeaway

In rats trained to self-administer methamphetamine, a hemp extract containing multiple cannabinoids was more effective than CBD isolate at reducing relapse-like behavior, and neither treatment was rewarding on its own.

Addiction researchers, cannabinoid pharmacologists, and scientists studying the entourage effect in therapeutic applications.

Hemp extract (2.5 mg/kg CBD) outperformed CBD isolate (80 mg/kg)

What the researchers found

All CBD-containing treatments reduced meth-primed reinstatement, but hemp extract (HE) and CBD+HE were more effective than CBD isolate alone. The hemp extract contained only 2.5 mg/kg CBD versus 80 mg/kg in the isolate, yet performed better. Neither cannabinoid treatment produced conditioned place preference (no rewarding properties). The 5-HT1A receptor was not involved.

Why it matters

Methamphetamine addiction has no approved pharmacotherapy. This study suggests full-spectrum hemp preparations may be more effective than pure CBD for preventing relapse, potentially at much lower CBD doses, supporting the entourage effect hypothesis in addiction treatment.

The numbers in context

CBD isolate: 80 mg/kg. Hemp extract: only 2.5 mg/kg CBD. All treatments reduced reinstatement. HE and CBD+HE more effective than CBD isolate. No CPP from any treatment. WAY-100635 (5-HT1A antagonist) did not block effects. All treatments reduced meth-induced sensitized hyperactivity.

How the study worked

Male Sprague-Dawley rats self-administered methamphetamine via lever press, underwent extinction, then reinstatement by meth injection. Four treatment conditions: vehicle, CBD isolate (80 mg/kg), hemp extract (HE, 2.5 mg/kg CBD + other cannabinoids), or CBD+HE (80 mg/kg total CBD). 5-HT1A antagonist co-administration tested. Conditioned place preference and behavioral sensitization also assessed.

What this study cannot tell us

Male rats only. Meth self-administration model may not fully capture human addiction. The hemp extract composition beyond CBD was not fully characterized. The 5-HT1A receptor was ruled out but other mechanisms were not tested.

How to read the evidence

Preliminary: well-designed animal study with multiple behavioral measures, but limited to male rats and a single addiction model.

When this study was published

Published 2026.

The bigger picture

The fact that a hemp extract with only 2.5 mg/kg CBD outperformed 80 mg/kg of pure CBD is striking. It suggests that minor cannabinoids or terpenes in the extract contribute meaningfully to anti-relapse effects, with major implications for cannabinoid product development in addiction medicine.

Questions still open

  • Which specific compounds in the hemp extract drive the superior effect? Would these results translate to human meth addiction? Could hemp extract-based treatments be developed for clinical trials? What other receptor systems are involved?

Common questions

Can CBD help prevent meth relapse?
In this rat study, both CBD and hemp extract reduced meth relapse-like behavior, but a full-spectrum hemp extract was significantly more effective than pure CBD, even at much lower CBD doses.
Is full-spectrum hemp better than CBD isolate for addiction?
This study found a hemp extract containing only 2.5 mg/kg CBD outperformed 80 mg/kg pure CBD for reducing meth relapse behavior in rats, strongly supporting the therapeutic advantage of multi-cannabinoid preparations.

Read the original research

A CBD-rich hemp extract is superior to CBD alone in reducing relapse to methamphetamine-seeking in rats.

Progress in neuro-psychopharmacology & biological psychiatry, 145, 111629

Citation

Umpierrez, Laísa S; Korkozian, Maral J; Costa, Priscila A; Anderson, Lyndsey L; McGregor, Iain S; Baracz, Sarah J; Perry, Christina J; Arnold, Jonathon C; Cornish, Jennifer L. (2026). A CBD-rich hemp extract is superior to CBD alone in reducing relapse to methamphetamine-seeking in rats.. Progress in neuro-psychopharmacology & biological psychiatry, 145, 111629. https://doi.org/10.1016/j.pnpbp.2026.111629

Explore the wider topic